Home > > North America And Global Chemiluminescence Immunoassay Market- Size, Share, Growth Rate, and Forecast
The North America Chemiluminescence Immunoassay market was valued at $3,097.7 Million in 2023, and is projected to reach $4,482.7 Million by 2030 growing at a CAGR of 5.47% from 2024 to 2030. Consumables segment is expected to be the highest contributor to this market, with $2,030.8 Million in 2023, and is anticipated to reach $2,898.2 by 2030, registering a CAGR of 5.26%. Instruments segment is anticipated to reach $1,207.8 Million by 2030 with the highest CAGR of 6.76%. Consumables and Instruments segments collectively expected to account for about 90.3% share of the North America Chemiluminescence Immunoassay market in 2023, with the former constituting around 65.6% share. Instruments and Consumables segments are expected to witness significant growth rates at a CAGR of 6.76% and 5.26% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 90.3% in the overall North America Chemiluminescence Immunoassay market in 2023, and is anticipated to reach 91.6% by 2030. Product Instruments Consumables Software & Services Application Therapeutic Drug Monitoring Oncology Cardiology Endocrinology Infectious Disease Autoimmune Disease Other Applications End-use Hospitals Clinical Laboratories Pharmaceutical & Biotechnology Companies Other End-Uses BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Singapore Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA